Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer: A nested case-control study

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 4, 1999, Pages 353-360

  Hansen, Svein ^a,b,c,d   Melby, K K ^a,b,c,d   Aase, S ^a,b,c,d   Jellum, E ^a,b,c,d   Vollset, S E ^a,b,c,d  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b Kreftforeningen   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

Adenocarcinoma; Cardia cancer; Gastric cancer; Helicobacter pylori; Nested case control study; Smoking; Socioeconomy

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOGENESIS; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SOCIOECONOMICS; STATISTICAL ANALYSIS; STOMACH CANCER;

EID: 0032957424     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750026353     Document Type: Article

References (37)

1. International Agency for Research on Cancer. Infection with Helicobacter pylori. In: Schistosomes, Liver Flukes and Helicobacter Pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7 14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994;61:177-240.
2. Forman D, Newell DG, Fullerton F, Yarnell JW, Stacey AR, Wald N, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. Br Med J 1991;302:1302-5.
3. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-31.
4. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991;325:1132-6.
5. Simán JH, Forsgren A, Berglund G, Florén C-H. Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. Scand J Gastroenterol 1997;32:1215-21.
6. Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 1995;15:603-6.
7. Webb PM, Yu MC, Forman D, Henderson BE, Newell DG, Yuan JM, et al. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996;67:603-7.
8. Aromaa A, Kosunen TU, Knekt P, Maatela J, Teppo L, Heinonen OP, et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996;144:142-9.
9. Jellum E, Andersen A, Lund Larsen P, Theodorsen L, Orjasaeter H. Experiences of the Janus Serum Bank in Norway. Environ Health Perspect 1995;103 Suppl 3:85-8.
10. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomized trial in healthy men. Lancet 1981;2:1303-10.
11. Bjartveit K, Foss OP, Gjervik T, Lund-Larsen P. The cardiovascular disease study in Norwegian counties: background and organization. Acta Med Scand 1979;634 Suppl:1-70.
12. Bjartveit K, Foss OP, Gjervik T. The cardiovascular disease study in Norwegian counties: Results from first screening. Acta Med Scand 1983;675 Suppl:1-184.
13. World Health Organization International Classification of Diseases for Oncology. 2nd Ed. Geneva: World Health Organization; 1990.
14. Laurén P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. APMIS 1965;64:31-49.
15. Meijer BC, Thijs JC, Kleibeuker JH, van Zwet AA, Berrelkamp RJ. Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori. J Clin Microbiol 1997;35:292-4.
16. van de Wouw BA, de Boer WA, Jansz AR, Staals AP, Roymans RT. Serodiagnosis of Helicobacter pylori infection: an evaluation of a commercially available ELISA-IgG. Neth J Med 1995;47:272-7.
17. Trautmann M, Moldrzyk M, Vogt K, Korber J, Held T, Marre R. Use of a receiver operating characteristic in the evaluation of two commercial enzyme immunoassays for detection of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis 1994;13:812-9.
18. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989.
19. SPSS Inc. SPSS Advanced Statistics 7.5. Chicago: SPSS Inc.: 1997.
20. Mehta C, Patel N. LocXact for Windows. Cambridge (MA): Cytel Software Corp.; 1996.
21. Hastic TJ, Tibshirani RJ. Generalized Additive Models. London: Chapman and Hall; 1990.
22. S-PLUS 4 for Windows. S-plus User's Guide. Seattle (WA): MathSoft; 1997.
23. Cole P, MacMahon B. Attributable risk percent in case-control studies. Br J Prev Soc Med 1971;25:242-4.
24. Rothman KJ. Modern Epidemiology. Boston. Little, Brown and Co.; 1986.
25. Karnes WE Jr, Samloff DA, Siurala M, Kekki M, Sipponen P, Kim SW, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
26. Osawa H, Inoue F, Yoshida Y. Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia. J Clin Pathol 1996;49:112-5.
27. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991;83:640-3.
28. Aukee S, Krohn K. Occurrence and progression of gastritis in patients operated on for peptic ulcer. Scand J Gastroenterol 1972;7:541-6.
29. Lynch DA, Mapstone NP, Clarke AM, Jackson P, Dixon MF, Quirke P, et al. Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 1995;36:351-3.
30. Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1-27.
31. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet 1992;339:896-7.
32. Hansson LE, Engstrand L, Nyren O, Evans DJ Jr, Lindgren A, Bergstrom R, et al. Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993;105:1098-103.
33. Graham DY. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model. Gastroenterology 1997;113:1983-91.
34. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
35. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440-3.
36. McColl KE. What remaining questions regarding Helicobacter pylori and associated diseases should be addressed by future research? View from Europe. Gastroenterology 1997;113:S158-62.
37. Hansen S, Wiig JN, Giercksky KE, Tretli S. Esophageal and gastric carcinoma in Norway 1958-1992: Incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer 1997;71:340-4.